Dianthus Therapeutics (DNTH) Return on Equity (2018 - 2025)

Dianthus Therapeutics has reported Return on Equity for 8 years, with the latest figure at 0.0% in Q4 2025.

• For the quarter ending Q4 2025, Return on Equity changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2024 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Equity for Q4 2025 stood at 0.0%, up from 0.0% in the prior quarter.
• The five-year high for Return on Equity was 0.04% in Q1 2022, with the low at 0.01% in Q4 2021.
• Average Return on Equity over 5 years is 0.0%, with a median of 0.0% recorded in 2023.
• Year-over-year, Return on Equity gained 4 bps in 2022 and decreased 3 bps in 2023.
• Tracing DNTH's Return on Equity over 5 years: stood at 0.01% in 2021, then soared by 278 bps to 0.01% in 2022, then plunged by 117 bps to 0.0% in 2023, then declined by 2 bps to 0.0% in 2024, then gained by 26 bps to 0.0% in 2025.
• The last three Return on Equity figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.

Peer Comparison